Yale Review: How Brain Alterations Contribute to Suicidal Thoughts and Behaviors
How brain alterations contribute to suicidal thoughts and behaviors is the subject of a new published review of brain scanning studies by Yale and international researchers. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience, and Professor of Psychiatry, in the Child Study Center and of Radiology and Biomedical Imaging at Yale, is the paper's lead and corresponding author.
Research Suggests Male and Female Children's Brains Respond to Differently to Technology
A 2018 study by Marc Potenza, MD, PhD, Professor of Psychiatry, in the Child Study Center and of Neuroscience, is cited in a Wall Street Journal Report that investigates brain differences that cause boys to be more interested in video games and girls to spend more time on social media.
Suicide is Preventable. So, How Can We Help Our Teens?
Suicide is preventable, but rates of suicide are increasing worldwide, and it is now the second leading cause of death in adolescents and young adults (unintentional motor vehicle accidents are first). Going to the emergency room may be the smartest thing these teenagers can do.
Picciotto to be Recognized with Marion Spencer Fay Award
The Institute for Women’s Health and Leadership of Drexel University College of Medicine will award its 2020 Marion Spencer Fay Award to Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology at Yale School of Medicine.
Blood Pressure Control Less Likely Among Those Treated in Low-income Areas
People enrolled in a large clinical hypertension management trial were half as likely to control their blood pressure if they received care at clinics and primary care practices in low-income areas, according to new Yale-led research.
Arnsten Appointed the Kent Professor of Neuroscience and of Psychology
Amy F.T. Arnsten, PhD, recently named as the Albert E. Kent Professor of Neuroscience and of Psychology, studies molecular influences on higher cognitive function, with the aim of developing rational therapies for mental illness and for age-related cognitive disorders such as Alzheimer’s disease.
Chen and Team Win Award from 2019 NIDA $100K SUD Startup Challenge
Kevin Chen, MD, fellow, National Clinical Scholars Program, and his team recently won an award as part of the 2019 NIDA $100K SUD Startup Challenge. Sponsored by the National Institute on Drug Abuse, the award is given to 10 winners for their startup projects to improve the well-being of those with substance use disorders.
More women in U.S. receive 3-D mammography but disparities remain
Use of 3-D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale Cancer Center researchers in a new study. But adoption of the technology varies widely, reflecting emerging disparities in care, they said.
Study: Accuracy of Five Self‐Report Screening Instruments for Substance Use in Pregnancy
Nearly one-fourth of pregnant women report having used alcohol, tobacco, or other substances in the past month, yet current screening questionnaires used by physicians may not accurately identify many of them. Kimberly A. Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services at Yale School of Medicine, was the senior researcher among investigators across three universities who compared results of five commonly used questionnaires against laboratory testing.
Assuring Gender Safety and Equity in Health Care: The Time for Action Is Now
TIME'S UP, a national effort to ensure workplace safety and equity, was launched in 2018 in response to allegations of sexual harassment and assault by persons in the entertainment industry and propelled the long-established #MeToo movement back into the public eye.
Federal Guidelines May Inadvertently Restrict Women’s Access to Effective HIV Protection
Restrictive recommendations for pre-exposure prophylaxis (or PrEP) issued by the Centers for Disease Control and Prevention (CDC) systematically disqualified nearly all women at risk for HIV and/or motivated to use the medication, researchers at the Yale School of Public Health and George Washington University have found.